Cargando…
Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients
In late 2019, a novel coronavirus (SARS-CoV-2) emerged in Wuhan, capital city of Hubei province in China. Cases of SARS-CoV-2 infection quickly grew by several thousand per day. Less than 100 days later, the World Health Organization declared that the rapidly spreading viral outbreak had become a gl...
Autores principales: | Rogers, Christopher J., Harman, Robert J., Bunnell, Bruce A., Schreiber, Martin A., Xiang, Charlie, Wang, Fu-Sheng, Santidrian, Antonio F., Minev, Boris R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7232924/ https://www.ncbi.nlm.nih.gov/pubmed/32423449 http://dx.doi.org/10.1186/s12967-020-02380-2 |
Ejemplares similares
-
Adipose Tissue-Derived Mesenchymal Stem Cells
por: Bunnell, Bruce A.
Publicado: (2021) -
The ratio of ADSCs to HSC-progenitors in adipose tissue derived SVF may provide the key to predict the outcome of stem-cell therapy
por: Kilinc, Mehmet Okyay, et al.
Publicado: (2018) -
In Vitro Culture Expansion Shifts the Immune Phenotype of Human Adipose-Derived Mesenchymal Stem Cells
por: Jeske, Richard, et al.
Publicado: (2021) -
Competitive DNA transfection formulation via electroporation for human adipose stem cells and mesenchymal stem cells
por: Flanagan, Michael, et al.
Publicado: (2012) -
Delivery of oncolytic vaccinia virus by matched allogeneic stem cells overcomes critical innate and adaptive immune barriers
por: Draganov, Dobrin D., et al.
Publicado: (2019)